Pazopanib for the maintenance treatment of epithelial ovarian, fallopian and peritoneal cancer [ID545]

  • Discontinued
  • GID-TAG444

Documents

Documents created during the development process.

Ovarian (epithelial), fallopian and peritoneal cancer - pazopanib (maintenance): appendix B - draft scope for consultation (pre-referral) - June 2013

Ovarian (epithelial), fallopian and peritoneal cancer - pazopanib (maintenance): appendix C - provisional matrix (pre-referral) - June 2013